Matches in SemOpenAlex for { <https://semopenalex.org/work/W2066226950> ?p ?o ?g. }
- W2066226950 endingPage "806" @default.
- W2066226950 startingPage "797" @default.
- W2066226950 abstract "Abstract Preclinical studies and initial clinical trials have documented the feasibility of adenoassociated virus (AAV)–mediated gene therapy for hemophilia B. In an 8-year study, inhibitor-prone hemophilia B dogs (n = 2) treated with liver-directed AAV2 factor IX (FIX) gene therapy did not have a single bleed requiring FIX replacement, whereas dogs undergoing muscle-directed gene therapy (n = 3) had a bleed frequency similar to untreated FIX-deficient dogs. Coagulation tests (whole blood clotting time [WBCT], activated clotting time [ACT], and activated partial thromboplastin time [aPTT]) have remained at the upper limits of the normal ranges in the 2 dogs that received liver-directed gene therapy. The FIX activity has remained stable between 4% and 10% in both liver-treated dogs, but is undetectable in the dogs undergoing muscle-directed gene transfer. Integration site analysis by linear amplification–mediated polymerase chain reaction (LAM-PCR) suggested the vector sequences have persisted predominantly in extrachromosomal form. Complete blood count (CBC), serum chemistries, bile acid profile, hepatic magnetic resonance imaging (MRI) and computed tomography (CT) scans, and liver biopsy were normal with no evidence for tumor formation. AAV-mediated liver-directed gene therapy corrected the hemophilia phenotype without toxicity or inhibitor development in the inhibitor-prone null mutation dogs for more than 8 years." @default.
- W2066226950 created "2016-06-24" @default.
- W2066226950 creator A5006018645 @default.
- W2066226950 creator A5007519593 @default.
- W2066226950 creator A5016603833 @default.
- W2066226950 creator A5060779925 @default.
- W2066226950 creator A5078803622 @default.
- W2066226950 creator A5079585808 @default.
- W2066226950 creator A5083658192 @default.
- W2066226950 creator A5086755266 @default.
- W2066226950 creator A5011445020 @default.
- W2066226950 date "2009-01-22" @default.
- W2066226950 modified "2023-10-16" @default.
- W2066226950 title "Long-term correction of inhibitor-prone hemophilia B dogs treated with liver-directed AAV2-mediated factor IX gene therapy" @default.
- W2066226950 cites W148295968 @default.
- W2066226950 cites W1487084354 @default.
- W2066226950 cites W1512913625 @default.
- W2066226950 cites W1896263756 @default.
- W2066226950 cites W1975528602 @default.
- W2066226950 cites W1976329054 @default.
- W2066226950 cites W1993774764 @default.
- W2066226950 cites W2006076378 @default.
- W2066226950 cites W2007261697 @default.
- W2066226950 cites W2019629950 @default.
- W2066226950 cites W2024157997 @default.
- W2066226950 cites W2046740401 @default.
- W2066226950 cites W2049592320 @default.
- W2066226950 cites W2062673895 @default.
- W2066226950 cites W2065451039 @default.
- W2066226950 cites W2068231681 @default.
- W2066226950 cites W2073545118 @default.
- W2066226950 cites W2073739917 @default.
- W2066226950 cites W2075227451 @default.
- W2066226950 cites W2075638876 @default.
- W2066226950 cites W2075953769 @default.
- W2066226950 cites W2078666065 @default.
- W2066226950 cites W2083788869 @default.
- W2066226950 cites W2088797435 @default.
- W2066226950 cites W2090607175 @default.
- W2066226950 cites W2109215179 @default.
- W2066226950 cites W2111742323 @default.
- W2066226950 cites W2117712095 @default.
- W2066226950 cites W2119164964 @default.
- W2066226950 cites W2122874617 @default.
- W2066226950 cites W2124000504 @default.
- W2066226950 cites W2130515212 @default.
- W2066226950 cites W2141577577 @default.
- W2066226950 cites W2150292142 @default.
- W2066226950 cites W2151713466 @default.
- W2066226950 cites W2153867928 @default.
- W2066226950 cites W2155710930 @default.
- W2066226950 cites W2171427593 @default.
- W2066226950 cites W2271547753 @default.
- W2066226950 cites W2325885736 @default.
- W2066226950 cites W2329607508 @default.
- W2066226950 cites W4250446838 @default.
- W2066226950 cites W99745469 @default.
- W2066226950 doi "https://doi.org/10.1182/blood-2008-10-181479" @default.
- W2066226950 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2630266" @default.
- W2066226950 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18957684" @default.
- W2066226950 hasPublicationYear "2009" @default.
- W2066226950 type Work @default.
- W2066226950 sameAs 2066226950 @default.
- W2066226950 citedByCount "238" @default.
- W2066226950 countsByYear W20662269502012 @default.
- W2066226950 countsByYear W20662269502013 @default.
- W2066226950 countsByYear W20662269502014 @default.
- W2066226950 countsByYear W20662269502015 @default.
- W2066226950 countsByYear W20662269502016 @default.
- W2066226950 countsByYear W20662269502017 @default.
- W2066226950 countsByYear W20662269502018 @default.
- W2066226950 countsByYear W20662269502019 @default.
- W2066226950 countsByYear W20662269502020 @default.
- W2066226950 countsByYear W20662269502021 @default.
- W2066226950 countsByYear W20662269502022 @default.
- W2066226950 countsByYear W20662269502023 @default.
- W2066226950 crossrefType "journal-article" @default.
- W2066226950 hasAuthorship W2066226950A5006018645 @default.
- W2066226950 hasAuthorship W2066226950A5007519593 @default.
- W2066226950 hasAuthorship W2066226950A5011445020 @default.
- W2066226950 hasAuthorship W2066226950A5016603833 @default.
- W2066226950 hasAuthorship W2066226950A5060779925 @default.
- W2066226950 hasAuthorship W2066226950A5078803622 @default.
- W2066226950 hasAuthorship W2066226950A5079585808 @default.
- W2066226950 hasAuthorship W2066226950A5083658192 @default.
- W2066226950 hasAuthorship W2066226950A5086755266 @default.
- W2066226950 hasBestOaLocation W20662269501 @default.
- W2066226950 hasConcept C104317684 @default.
- W2066226950 hasConcept C111599444 @default.
- W2066226950 hasConcept C126322002 @default.
- W2066226950 hasConcept C2775934546 @default.
- W2066226950 hasConcept C2777766500 @default.
- W2066226950 hasConcept C2778261982 @default.
- W2066226950 hasConcept C2778382381 @default.
- W2066226950 hasConcept C2781221834 @default.
- W2066226950 hasConcept C2992139802 @default.
- W2066226950 hasConcept C55493867 @default.
- W2066226950 hasConcept C71924100 @default.